1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Stem Cell Therapy 1.3 Market by Application 1.3.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Diagnostic Centres 1.3.4 Clinics 1.3.5 Retail Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Perspective (2016-2027) 2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions 2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Industry Dynamic 2.3.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Trends 2.3.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Drivers 2.3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Challenges 2.3.4 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue 3.1.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue (2016-2021) 3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue 3.4 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio 3.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2020 3.5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served 3.6 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service 3.7 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Type 4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Type (2016-2021) 4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2022-2027) 5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Application 5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Application (2016-2021) 5.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027) 6.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type 6.2.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) 6.2.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) 6.2.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027) 6.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application 6.3.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) 6.3.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) 6.3.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027) 6.4 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country 6.4.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) 6.4.2 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027) 7.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type 7.2.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) 7.2.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) 7.2.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027) 7.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application 7.3.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) 7.3.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) 7.3.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027) 7.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country 7.4.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) 7.4.2 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027) 8.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type 8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application 8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region 8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027) 9.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type 9.2.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027) 9.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application 9.3.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027) 9.4 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country 9.4.1 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2016-2027) 10.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type 10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application 10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country 10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 GNT Pharma 11.1.1 GNT Pharma Company Details 11.1.2 GNT Pharma Business Overview 11.1.3 GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction 11.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) 11.1.5 GNT Pharma Recent Development 11.2 Amkor Pharma 11.2.1 Amkor Pharma Company Details 11.2.2 Amkor Pharma Business Overview 11.2.3 Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction 11.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) 11.2.5 Amkor Pharma Recent Development 11.3 Synthetic Biologics 11.3.1 Synthetic Biologics Company Details 11.3.2 Synthetic Biologics Business Overview 11.3.3 Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction 11.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) 11.3.5 Synthetic Biologics Recent Development 11.4 Mitsubishi Tanabe Pharma 11.4.1 Mitsubishi Tanabe Pharma Company Details 11.4.2 Mitsubishi Tanabe Pharma Business Overview 11.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction 11.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) 11.4.5 Mitsubishi Tanabe Pharma Recent Development 11.5 Avicena 11.5.1 Avicena Company Details 11.5.2 Avicena Business Overview 11.5.3 Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction 11.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) 11.5.5 Avicena Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction 11.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) 11.6.5 Sanofi Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Stem Cell Therapy Table 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2016-2021) Table 8. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2022-2027) Table 10. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Trends Table 11. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Drivers Table 12. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Challenges Table 13. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Restraints Table 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players (2016-2021) Table 16. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2020) Table 17. Ranking of Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service Table 21. Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. GNT Pharma Company Details Table 62. GNT Pharma Business Overview Table 63. GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Table 64. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million) Table 65. GNT Pharma Recent Development Table 66. Amkor Pharma Company Details Table 67. Amkor Pharma Business Overview Table 68. Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Table 69. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million) Table 70. Amkor Pharma Recent Development Table 71. Synthetic Biologics Company Details Table 72. Synthetic Biologics Business Overview Table 73. Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Table 74. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million) Table 75. Synthetic Biologics Recent Development Table 76. Mitsubishi Tanabe Pharma Company Details Table 77. Mitsubishi Tanabe Pharma Business Overview Table 78. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Table 79. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million) Table 80. Mitsubishi Tanabe Pharma Recent Development Table 81. Avicena Company Details Table 82. Avicena Business Overview Table 83. Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Table 84. Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million) Table 85. Avicena Recent Development Table 86. Sanofi Company Details Table 87. Sanofi Business Overview Table 88. Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Table 89. Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) & (US$ Million) Table 90. Sanofi Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Features Figure 3. Stem Cell Therapy Features Figure 4. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Diagnostic Centres Case Studies Figure 7. Clinics Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Report Years Considered Figure 10. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Regions (2022-2027) Figure 14. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Players in 2020 Figure 15. Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2020 Figure 17. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027) Figure 21. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027) Figure 22. North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027) Figure 23. United States Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027) Figure 27. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027) Figure 28. Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027) Figure 29. Germany Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027) Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Region (2016-2027) Figure 39. China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027) Figure 47. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027) Figure 48. Latin America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027) Figure 49. Mexico Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application (2016-2027) Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Country (2016-2027) Figure 55. Turkey Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. GNT Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) Figure 59. Amkor Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) Figure 60. Synthetic Biologics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) Figure 61. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) Figure 62. Avicena Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) Figure 63. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

GNT Pharma Amkor Pharma Synthetic Biologics Mitsubishi Tanabe Pharma Avicena Sanofi